We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HVN:ASXHarvey Norman Holdings Ltd Analysis

Data as of 2026-03-14 - not real-time

A$5.14

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Harvey Norman is trading at AUD 5.14, well beneath its 20‑day SMA of 5.83, 50‑day SMA of 6.31 and 200‑day SMA of 6.52, indicating a pronounced bearish technical stance. The RSI of 18.9 places the stock in oversold territory, while the MACD line sits below its signal line, reinforcing short‑term downside momentum. The price hovers just above the identified support level of 5.09 and faces resistance near 6.48, suggesting limited upside unless a bounce occurs. Despite the technical weakness, the company offers a robust 5.64% dividend yield with a payout ratio of roughly 60%, supported by solid operating cash flow and a free cash flow generation of over AUD 0.75 bn. Volatility is elevated at 34.9% over the past 30 days, yet the beta of 0.34 signals low sensitivity to broader market moves, which may cushion broader equity swings.
Fundamentally, HVN posted 11.6% revenue growth, healthy operating margins (26.5%) and a respectable ROE of 11.8%. The balance sheet shows AUD 3.85 bn in cash against AUD 2.46 bn of debt, yielding a debt‑to‑equity ratio below 50%, a manageable level for a retailer with substantial property assets. The discounted cash‑flow model values the shares near AUD 11.77, implying an upside of roughly 27% from current levels, while analyst consensus remains a “buy” with a median target of AUD 6.55. These factors together suggest that the stock is fundamentally sound but currently penalized by technical weakness, creating a potential entry point for dividend‑focused investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near immediate support with bearish technical indicators
  • High dividend yield provides downside cushion
  • Limited upside until price breaks resistance at 6.48

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • Sustained cash flow generation supports dividend and debt service
  • Analyst consensus and target price indicate upside potential

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Stable business model across retail, franchise and property assets
  • Attractive dividend yield for income‑oriented investors
  • Long‑term upside embedded in DCF valuation and low market beta

Key Metrics & Analysis

Financial Health

Revenue Growth11.60%
Profit Margin18.13%
P/E Ratio11.4
ROE11.78%
ROA5.77%
Debt/Equity49.80
P/B Ratio1.3
Op. Cash FlowA$639.1M
Free Cash FlowA$755.8M

Technical Analysis

TrendBearish
RSI18.9
SupportA$5.09
ResistanceA$6.48
MA 20A$5.83
MA 50A$6.31
MA 200A$6.52
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueA$11.77
Target PriceA$6.55
Upside/Downside27.48%
GradeUndervalued
TypeValue
Dividend Yield5.64%

Risk Assessment

Beta0.34
Volatility34.86%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.